How many shares of CLDX does UBS Group AG own?

As of 2026-Q2, UBS Group AG holds 481,997 shares of CLDX (Celldex Therapeutics, Inc.).

What is UBS Group AG's CLDX position worth?

As of 2026-Q2, UBS Group AG's CLDX position is worth $17.9M.

In 2026-Q2, UBS Group AG increased their CLDX position (+62.3% change in shares).

Based on available 13F filings, UBS Group AG first reported a position in CLDX in 2019-Q1. They have held the position across 30 quarters.

Position history for UBS Group AG's holdings in Celldex Therapeutics, Inc.

Current Value

$17.9M

Current Shares

481,997

Total Value Change

+$17.9M

Total Shares Change

+481,796

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	481,997	+62.3%	$17.9M	0.0%	$37.21	41
2026-Q1	Decreased	296,970	-9.0%	$9.4M	0.0%	$28.94	0
2025-Q4	Decreased	326,462	-21.6%	$8.9M	0.0%	$26.43	0
2025-Q3	Decreased	416,447	-50.5%	$10.8M	0.0%	$26.19	0
2025-Q2	Decreased	841,246	-42.7%	$17.1M	0.0%	$20.29	0
2025-Q1	Increased	1.5M	+276.7%	$26.6M	0.0%	$19.93	46
2024-Q4	Increased	389,797	+134.0%	$9.9M	0.0%	$25.12	45
2024-Q3	Increased	166,597	+3.7%	$5.7M	0.0%	$33.20	28
2024-Q2	Decreased	160,596	-37.4%	$5.9M	0.0%	$37.01	0
2024-Q1	Increased	256,348	+62.1%	$10.8M	0.0%	$41.97	40
2023-Q4	Increased	158,092	+645.9%	$6.3M	0.0%	$39.66	44
2023-Q3	Increased	21,195	+2627.8%	$583,286	0.0%	$27.52	39
2023-Q2	Decreased	777	-98.7%	$26,364	0.0%	$34.58	0
2023-Q1	Decreased	60,875	-49.0%	$2.2M	0.0%	$35.58	0
2022-Q4	Increased	119,243	+222.9%	$5.3M	0.0%	$44.57	44
2022-Q3	Decreased	36,928	-50.3%	$1M	0.0%	$28.35	0
2022-Q2	Decreased	74,278	-53.8%	$2M	0.0%	$27.83	0
2022-Q1	Increased	160,779	+23.1%	$5.5M	0.0%	$34.59	33
2021-Q4	Increased	130,590	+175.9%	$5M	0.0%	$38.90	43
2021-Q3	Increased	47,326	+133.0%	$2.6M	0.0%	$51.97	42
2021-Q2	Decreased	20,313	-63.0%	$679,000	0.0%	$35.37	0
2021-Q1	Increased	54,849	+1888.7%	$1.1M	0.0%	$19.73	41
2020-Q4	Increased	2,758	+75.7%	$48,000	0.0%	$17.88	21
2020-Q3	Increased	1,570	+166.1%	$23,000	0.0%	$15.19	21
2020-Q2	Decreased	590	-34.2%	$7,000	0.0%	$12.48	0
2020-Q1	Decreased	897	-40.8%	$1,000	0.0%	$1.77	0
2019-Q4	Decreased	1,515	-68.1%	$3,000	0.0%	$2.20	0
2019-Q3	Increased	4,747	+35.6%	$10,000	0.0%	$2.17	15
2019-Q2	Increased	3,501	+1641.8%	$10,000	0.0%	$2.68	19
2019-Q1	New	201	-	$1,000	0.0%	$4.92	17